Randomized trial of protease inhibitor-including vs. protease inhibitor-sparing regimens for women who initiate therapy of HIV infection during pregnancy.

Trial Profile

Randomized trial of protease inhibitor-including vs. protease inhibitor-sparing regimens for women who initiate therapy of HIV infection during pregnancy.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2013

At a glance

  • Drugs Nelfinavir (Primary) ; Lamivudine; Nevirapine; Zidovudine
  • Indications HIV infections; HIV-1 infections; Pregnancy
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 06 Apr 2012 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
    • 08 Feb 2009 Preliminary results were presented at CROI 2009.
    • 16 Sep 2008 Checked against NCT00017719.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top